BioDuro

Summary
About Us
Resources
Contact
Related Service Categories

BioDuro

9601 Jeronimo Road

Irvine, CA 92618

United States

BioDuro is a US company founded in 1996, and headquartered in Irvine, California. With more than 2,000+ scientists, we have 7 R&D and manufacturing campuses across the US and China. We offer fully integrated CRDMO services from discovery to commercial manufacturing across medicinal chemistry, biology, DMPK, drug substance and drug product, including multiple modalities small molecules, peptides, oligonucleotides and antibody drug conjugates. We leverage our broad capabilities and unique technology platforms to empower biotech and pharmaceutical partners worldwide. Our integrated approaches accelerate and de-risk new drug discovery and development, creating higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, innovative and people-focused culture. As a pure-play CRDMO, BioDuro operates under one global standard, providing integrated, fast, and flexible services to meet the unique needs of our clients and accelerate development timelines.

Company Description

BioDuro is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) providing fully integrated solutions from discovery through commercial manufacturing including chemistry, biology, DMPK, drug substance and drug product. Our expertise spans small molecules, peptides, ADCs, TPD and biologics, supporting clients across every stage of the drug development lifecycle. With deep scientific expertise and global operations, BioDuro accelerates timelines and enhances program success through flexible, end-to-end partnerships rooted in quality, innovation, and collaboration.

Company Background

Founded in 1996, BioDuro has grown into a trusted global partner for pharmaceutical and biotech companies worldwide. Our cross-functional scientific teams bring extensive experience in chemistry, biology, DMPK, CMC, and analytical development, combining global scale with local expertise. We are committed to enabling innovation by offering integrated, science-driven solutions that deliver faster, smarter, and more reliable drug development outcomes.

Facilities

BioDuro operates eight sites across the U.S., mainland China and Taiwan, including R&D and GMP manufacturing facilities. Our campuses feature state-of-the-art laboratories, plants, and high-containment suites (up to OEB-5) supporting HPAPI, peptide, and small molecule development at all scales. Each site is designed to ensure quality, compliance, and scalability, providing seamless technology transfer and efficient project execution across the entire value chain.

Services and Capabilities

BioDuro offers integrated discovery, development, and manufacturing services encompassing medicinal chemistry, biology, DMPK, bioanalytical, drug substance and drug product to over 1,500 clients every year. Our specialized expertise includes peptides, GLP-1s, ADCs, TPD and traditional small molecules from IND submission to commercial launch. Through our end-to-end CRDMO platform, we provide flexible collaboration models, rapid timelines, and tailored scientific strategies that help clients advance programs from concept to clinic efficiently and with confidence.

Pharmacovigilance in Australia and New Zealand
Drug safety in Australia is regulated via the Office of Medicines Safety Monitoring (OMSM) (synonymous with Adverse Drug Reaction Advisory Committee), a branch of the Therapeutic Goods Administration (TGA). In New Zealand, Medsafe is the regulatory agency responsible for overseeing drug safety/ ...
Drug Supply Modelling in Clinical Trials (Statistical Methodology)
Drug supply chain is very costly and is a well-recognized bottleneck at the design and managing of clinical trials. The innovative risk-based statistical approach to modelling drug supply demand for a single study is proposed. The approach uses the developed technique for predicting the number of ...
Criteria for CMO Selection
Major pharmaceutical and emerging biopharmaceutical companieshave a plethora of choices in utilizing contract-manufacturingorganizations (CMOs) available in the global market place for their custom synthesis needs. However, establishing a collaborative relationship with a few manageable and reliable...
Off-shoring Stability Testing Conducting Cost-efficient Compliant Long-term Stability Studies at Overseas CRO’...
The research-based pharmaceutical industry has always accommodated change, and like other businesses, is increasingly becoming cost constrained due in part to the rising investment required to develop new medicines and the global economic environment.
Biopharmaceutical Contract Manufacturing Market: Outsourcing – What Services are Biomanufacturing Directors ...
As the world economy and financial markets contracted in 2009, so did the market for biopharmaceutical contract manufacturer services.
Outsourcing Compound Inventory Trend or Real Benefits?
A screening compound collection is recognized as a valuable asset by most pharmaceutical companies and Compound Management is now a key component of the Drug Discovery process.